OP20: Expanding the genetic spectrum of inflammatory bowel disease through large-scale exome sequencingECCO'25 Berlin
2025
OP21: MIF-CD74 signaling promotes intestinal LTi-like ILC3s activation and gut fibrosis via upregulating pSTAT3ECCO'25 Berlin
2025
OP22: NR1D1 Deficiency Induces CD47 Upregulation Impairing Macrophage Efferocytosis and Exacerbating Intestinal Inflammation in Ulcerative ColitisECCO'25 Berlin
2025
OP23: Neutrophil Niches and Therapy Resistance in Ulcerative Colitis: Spatial Atlas InsightsECCO'25 Berlin
2025
OP24: TL1A-activated T cells as upstream regulators of perianal fistulizing disease-associated changes in the rectum of Crohn's Disease patientsECCO'25 Berlin
2025
OP25: Lymphocytic colitis can be transcriptionally divided into channelopathic and inflammatory lymphocytic colitisECCO'25 Berlin
2025
OP26: Disentangling the role of HLA proteins in shaping the T-cell repertoire in Inflammatory Bowel Disease using CDR3-QTL analysisECCO'25 Berlin
2025
OP27: Unlocking Inflammatory Bowel Disease subtypes: a deep dive into transcriptomics and Machine LearningECCO'25 Berlin
2025
OP28: Anti-integrin αvβ6 autoantibodies are detected in preclinical, incident and established colonic Crohn’s diseaseECCO'25 Berlin
2025
OP29: Breaking New Ground in IBD Research: Organoid Models as the Vanguard for Personalized TherapiesECCO'25 Berlin
2025
OP30: Dissecting the genetic basis of clinical phenotype heterogeneity within IBD in more than 63,000 IBD patientsECCO'25 Berlin
2025
OP31: Phase 1b study of SOR102, a novel, orally delivered bispecific anti-TNF/anti-IL-23 domain antibody in patients with mild to severe ulcerative colitisECCO'25 Berlin
2025
OP32: Identifying clusters of antibiotic use patterns after the first episode of pouchitis in a population-based cohortECCO'25 Berlin
2025